Affiliation:
1. Division of Endocrinology, Diabetes and Metabolism University of California, San Diego La Jolla California USA
2. Department of Endocrinology, Diabetes and Metabolism Veterans Affairs San Diego La Jolla California USA
Abstract
AbstractThe global prevalence and increasing incidence rates of type 2 diabetes (T2D) have rippling effects on healthcare costs and diminishing quality of life. Despite advances in technology, continuous subcutaneous insulin infusion (CSII), or insulin pump therapy, is rarely being recommended by healthcare professionals and is underutilized in T2D management. This review analyses the available literature on CSII use in T2D patients. In addition, it discusses which groups of patients may benefit from CSII, identifies potential challenges associated with CSII use, and suggests future directions for research to expand the applicability of this technology to the broader T2D population.
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine